Soccer Star Eran Zahavi and Influencer Ben Zini Vie for Dominance in Israel's Padel Market
A burgeoning business rivalry has emerged in Israel's rapidly expanding padel industry, pitting soccer superstar Eran Zahavi against social media influencer and entertainer Ben Zini. Both are investing heavily, but with distinctly different strategies.
Ben Zini has opted for a compact and rapid model, establishing an indoor padel facility in Glilot. This venue boasts an impressive 97% occupancy rate and generated over 700,000 shekels in its first month, promising a swift return on investment. Zini's income streams outside of padel include advertising campaigns, digital collaborations, performances, music, and commercial real estate ventures, leveraging his large online following.
Eran Zahavi, on the other hand, is aiming to build a long-term, expansive empire. His approach involves creating a premium experience at a new facility in Ra'anana and establishing a national league to foster a broad competitive structure within the sport. Zahavi's substantial wealth, estimated at 250 million shekels, stems primarily from his lucrative international soccer career, with significant investments in real estate, sports-tech startups, and commercial sponsorships.
The competition highlights Zini's focus on efficiency and immediate returns against Zahavi's strategic, long-term market control. Zini's model offers lower risk and quick cash flow, while Zahavi's strategy targets building a dominant market presence over time.
In terms of financial commitment, Ben Zini invested approximately 3 million shekels in his Glilot facility. Eran Zahavi has made the larger investment, injecting 12 million shekels into his Ra'anana project and league development, positioning him as the leading investor in the Israeli padel market.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.